The full exciting schedule has been announced for the SelectScience® Virtual Cancer and Immunology Research Summit 2021, launching on May 11, 2021.
Free Registration |
Now in its second year, the Virtual Cancer and Immunology Research Summit will cover major new developments in cancer and immunology research, from cutting-edge technologies to novel techniques and top resources to advance your work.
Register free now to watch talks by an outstanding lineup of world-class speakers and leading manufacturers, join live Q&As and dedicated networking sessions, explore virtual resource hubs and discover the latest product launches and application news for your area of expertise.
Among those invited to present will be Dr. Chris Halbrook, assistant professor at the University of California, Irvine (UCI), who highlights the significance of the event: "I view this Summit as a great forum to share the research advances of my group with an audience of wide-ranging interests. Much of the success I have had in my career has come through collaborative efforts, and I certainly expect this Summit to lead to some exciting new ideas and interactions."
Register now to reserve your free place and read on to learn more about:
Dr. Genevieve Boland Harvard Medical School Multi-modality approach to predicting and monitoring immunotherapy response and resistance |
Overcoming T cell homing challenges in CAR-T cell cancer therapies |
NMR-based metabolomics in breast cancer research |
Plasma proteomics predicts response to immunotherapy and provides biological insights into tumor-immune system interactions |
TCR targets validation through T cell activation |
Multi-modality approach to predicting and monitoring immunotherapy response and resistance |
Scientists' Choice Awards: Join us to celebrate the best new life sciences technologies of the year |
New advances in high-throughput drug screening using TrueGel3D® HTS Hydrogel 3D Cell Culture Plates |
Challenge and improve your DNA / RNA sample preparation: An introduction to bead-beating technology |
Targeting metabolism to treat pancreatic cancer |
Optimizing immunohistochemistry and multiplex immunofluorescence success with antibody validation |
The impact of COVID-19 on pediatric medulloblastoma: A global response |
Profiling of the immune system of multiple myeloma patients at diagnosis and after treatment using mass cytometry by time-of-flight (CyTOF) |
Proteomic analysis to predict response to immunotherapy |
Interrogating complex tumors by multiomic spatial profiling |
One workflow, endless options: NGS workflow solutions |
Cell-based assays to functionally characterize immunotherapy |
Identifying and targeting chromosome instability genes in cancer |
Get the most from your samples: Higher yields of higher-quality RNA and DNA using the Ionic® Purification System |
Predict anticancer efficacy with a new in vitro 3D modeling platform |
Targeting tumor mutations with personalized T cell therapy of cancer |
Evaluating the heterogeneity of B cells and TLS in lung cancer patients for improved immunotherapeutics |
Speaker split session: |
PD-1 mechanism of action: What do we know? |
Pharmacokinetic services: Tools for cancer research |
Register for free to reserve a place today — you’ll be able to drop in and out as you wish during the Summit.
Watch this space for further updates and follow our social media channels:
Catch up on the latest techniques and technologies and play your part in improving science communication by leaving a lab product review for a chance to win a $400 Amazon Gift Card.
Spread the word using #CancerImmunologySummit